These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 5471448)
1. Ion exchange processes at the neuromuscular junction of voluntary muscle. Taylor DB; Steinborn J; Lu TC J Pharmacol Exp Ther; 1970 Oct; 175(1):213-27. PubMed ID: 5471448 [No Abstract] [Full Text] [Related]
2. Affinity of curare-like compounds and their potency in blocking neuromuscular transmission. Lu TC J Pharmacol Exp Ther; 1970 Sep; 174(3):560-6. PubMed ID: 4247938 [No Abstract] [Full Text] [Related]
3. Stoichiometry of the drug-nicotinic receptor interaction. Parker RB; Goldfine C J Pharmacol Exp Ther; 1973 Jun; 185(3):649-52. PubMed ID: 4712655 [No Abstract] [Full Text] [Related]
4. [Mechanism of action of muscle relaxants]. Nishimura N; Yoshino M Masui; 1971 Feb; 20(2):160-5. PubMed ID: 4251038 [No Abstract] [Full Text] [Related]
5. The role of inorganic ions in ion exchange processes at the cholinergic receptor of voluntary muscle. Taylor DB J Pharmacol Exp Ther; 1973 Sep; 186(3):537-51. PubMed ID: 4728334 [No Abstract] [Full Text] [Related]
6. [Molecular theory about the mechanism of action of curare compounds]. Waser PG Anaesthesist; 1971 Jan; 20(1):23-9. PubMed ID: 4251063 [No Abstract] [Full Text] [Related]
7. The effect of neuromuscular blocking agents on acetylcholine release. Gergis SD; Dretchen KL; Sokoll MD; Long JP Proc Soc Exp Biol Med; 1971 Nov; 138(2):693-5. PubMed ID: 4330238 [No Abstract] [Full Text] [Related]
8. The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat. Katz RL; Eakins KE J Pharmacol Exp Ther; 1966 Nov; 154(2):303-9. PubMed ID: 5922992 [No Abstract] [Full Text] [Related]
9. The rate of action of competitive neuromuscular blocking agents. Waud DR J Pharmacol Exp Ther; 1967 Oct; 158(1):99-114. PubMed ID: 6054082 [No Abstract] [Full Text] [Related]
12. A new theory of the termination of action of the muscle relaxants. Feldman SA; Tyrrell MF Proc R Soc Med; 1970 Jul; 63(7):692-5. PubMed ID: 4317548 [No Abstract] [Full Text] [Related]
13. The interaction of hexafluorenium with other neuromuscular blocking agents in man. Foldes FF Anaesthesist; 1966 Mar; 15(3):75-8. PubMed ID: 4383609 [No Abstract] [Full Text] [Related]
14. Blockade of adrenal medullary stimulation in cats by competitive & depolarizing neuromuscular blocking agents. Patnaik GK; Dhawan BN Indian J Exp Biol; 1971 Jul; 9(3):362-4. PubMed ID: 5144335 [No Abstract] [Full Text] [Related]
15. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium. Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425 [No Abstract] [Full Text] [Related]
16. Histamine release from rat peritoneal mast cells and cat paws induced by some neuromuscular blocking agents. Frisk-Holmberg M; Strandberg K Acta Physiol Scand; 1971 Mar; 81(3):367-75. PubMed ID: 4101373 [No Abstract] [Full Text] [Related]
18. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium]. Danilov AF Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151 [No Abstract] [Full Text] [Related]
19. Muscle relaxants in small animal anesthesia. Lumb WV J Am Vet Med Assoc; 1972 Dec; 161(11):1436-41. PubMed ID: 4264297 [No Abstract] [Full Text] [Related]
20. Further studies on the neuromuscular effects of beta-diethylaminoethyl-diphenyl propylacetate hydrochloride (SKF-525-A). Suarez-Kurtz G; Paulo LG; Fonteles MC Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):185-95. PubMed ID: 5353875 [No Abstract] [Full Text] [Related] [Next] [New Search]